Allied Biotech Corporation

TPEX:1780 Stok Raporu

Piyasa değeri: NT$1.6b

Allied Biotech Temettü

Temettü kriter kontrolleri 4/6

Allied Biotech is a dividend paying company with a current yield of 4.97% that is well covered by earnings.

Anahtar bilgiler

5.0%

Temettü verimi

n/a

Geri Alım Getirisi

Toplam Hissedar Getirisin/a
Gelecekteki Temettü Verimin/a
Temettü Büyümesi7.3%
Bir sonraki temettü ödeme tarihin/a
Eski temettü tarihin/a
Hisse başına temettüNT$0.850
Ödeme oranı77%

Son temettü güncellemeleri

Recent updates

Is Allied Biotech Corporation (GTSM:1780) A Good Dividend Stock?

Apr 16
Is Allied Biotech Corporation (GTSM:1780) A Good Dividend Stock?

These 4 Measures Indicate That Allied Biotech (GTSM:1780) Is Using Debt Reasonably Well

Mar 05
These 4 Measures Indicate That Allied Biotech (GTSM:1780) Is Using Debt Reasonably Well

Allied Biotech (GTSM:1780) Has Compensated Shareholders With A Respectable 49% Return On Their Investment

Jan 24
Allied Biotech (GTSM:1780) Has Compensated Shareholders With A Respectable 49% Return On Their Investment

Is Allied Biotech Corporation (GTSM:1780) At Risk Of Cutting Its Dividend?

Jan 03
Is Allied Biotech Corporation (GTSM:1780) At Risk Of Cutting Its Dividend?

A Look At The Intrinsic Value Of Allied Biotech Corporation (GTSM:1780)

Dec 13
A Look At The Intrinsic Value Of Allied Biotech Corporation (GTSM:1780)

Is Allied Biotech (GTSM:1780) A Risky Investment?

Nov 25
Is Allied Biotech (GTSM:1780) A Risky Investment?

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: 1780 has been paying a dividend for less than 10 years and during this time payments have been volatile.

Büyüyen Temettü: 1780's dividend payments have increased, but the company has only paid a dividend for 9 years.


Piyasaya Karşı Temettü Getirisi

Allied Biotech Piyasaya Karşı Temettü Getirisi
1780 temettü verimi piyasa ile karşılaştırıldığında nasıldır?
SegmentTemettü Verimi
Şirket (1780)5.0%
Pazarın Alt %25'i (TW)1.7%
Pazarın En İyi %25'i (TW)4.4%
Sektör Ortalaması (Biotechs)2.4%
Analist tahmini (1780) (3 yıla kadar)n/a

Önemli Temettü: 1780's dividend (4.97%) is higher than the bottom 25% of dividend payers in the TW market (1.71%).

Yüksek Temettü: 1780's dividend (4.97%) is in the top 25% of dividend payers in the TW market (4.42%)


Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: At its current payout ratio (77.1%), 1780's payments are covered by earnings.


Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: With its reasonably low cash payout ratio (44.6%), 1780's dividend payments are well covered by cash flows.


Güçlü temettü ödeyen şirketleri keşfedin